Search This Blog

Monday, October 1, 2018

Vertex initiated at Cantor Fitzgerald


Vertex initiated with an Overweight at Cantor Fitzgerald. Cantor Fitzgerald analyst Alethia Young started Vertex Pharmaceuticals with an Overweight rating and $217 price target.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.